---
figid: PMC9545784__FCP-36-790-g004
pmcid: PMC9545784
image_filename: FCP-36-790-g004.jpg
figure_link: /pmc/articles/PMC9545784/figure/fcp12782-fig-0003/
number: FIGURE 3
figure_title: ''
caption: Effect of EDB on the expression of SOD and MDA in the hippocampus in mice
  with cerebral ischemia reperfusion injury evaluated. *P < 0.05; **P < 0.01; ns no
  statistical significance. N = 12 mice per group
article_title: Edaravone dexborneol protects cerebral ischemia reperfusion injury
  through activating Nrf2/HO‐1 signaling pathway in mice.
citation: Lili Xu, et al. Fundam Clin Pharmacol. 2022 Oct;36(5):790-800.
year: '2022'

doi: 10.1111/fcp.12782
journal_title: Fundamental & Clinical Pharmacology
journal_nlm_ta: Fundam Clin Pharmacol
publisher_name: John Wiley and Sons Inc.

keywords:
- cerebral ischemia reperfusion injury
- Edaravone dexborneol
- inflammation
- NADPH oxidase 2
- Nrf2/HO‐1 pathway

---
